Reechaipichitkul Wipa, Latong Sirikan
Department of Medicine, Srinagarind Hospital, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
Southeast Asian J Trop Med Public Health. 2005 Mar;36(2):474-80.
Massive hemoptysis is a life-threatening condition and can lead to asphyxiation. This is a retrospective review of 101 patients hospitalized with massive hemoptysis at Srinagarind Hospital, Khon Kaen, Thailand, between January 1993 and December 2002. The male to female ratio was 2.1:1. The average age was 47.1 (SD 16.8) years. Half the subjects were farmers and three-fourths had an underlying disease; most notably old pulmonary tuberculosis (41.6%). The mean duration of massive hemoptysis was 3.2 (SD 3.7) days. An initial hematocrit < or = 30% was found in 34.6% of patients, and a prolonged prothrombin time in 4.0%, and thrombocytopenia in 2.0%. Chest radiographs revealed unilateral, bilateral lesions and normal lungs in 57.4, 40.6, and 2.0%, respectively. A chest CT was done in 14.8% of patients. Bronchoscopy localized the bleeding and diagnosed the etiology in 19.8%. The most common causes of massive hemoptysis were bronchiectasis (33.7%), active pulmonary tuberculosis (20.8%) and malignancy (10.9%). Patients were grouped by treatment: 1) conservative (88); 2) emergency bronchial artery embolization (7); and, 3) emergency surgery (6). Of the 88 patients in group 1, the bleeding was stopped in 71 (80.7%) and recurred in 4. Of the 7 patients undergoing emergency bronchial artery embolization, the bleeding was stopped in 6 (86%) and recurred in 1. In the 6 patients who underwent emergency surgery, the bleeding was stopped in all and recurred in 1. Recurrent hemoptysis usually arose within 7 days of the first episode and was well controlled with bronchial arterial embolization. The mortality rate was 17.8%. Of the discharged patients, 36.1% had recurrent hemoptysis. Most of them occurred within one month after discharge. We conclude that, the most common cause of massive hemoptysis is benign rahter than malignant disease. Intensive care with conservative treatment should be applied vigorously. Bronchial artery embolization is an excellent, non-surgical alternative to control bleeding, and should be done before specific surgical intervention.
大咯血是一种危及生命的状况,可导致窒息。这是一项对1993年1月至2002年12月期间在泰国孔敬诗里拉吉医院住院的101例大咯血患者的回顾性研究。男女比例为2.1:1。平均年龄为47.1(标准差16.8)岁。一半的受试者是农民,四分之三有基础疾病;最常见的是陈旧性肺结核(41.6%)。大咯血的平均持续时间为3.2(标准差3.7)天。34.6%的患者初始血细胞比容≤30%,4.0%的患者凝血酶原时间延长,2.0%的患者血小板减少。胸部X线片显示单侧、双侧病变及肺部正常的患者分别占57.4%、40.6%和2.0%。14.8%的患者进行了胸部CT检查。支气管镜检查确定了出血部位并诊断出病因的患者占19.8%。大咯血最常见的原因是支气管扩张(33.7%)、活动性肺结核(20.8%)和恶性肿瘤(10.9%)。患者按治疗方法分组:1)保守治疗(88例);2)急诊支气管动脉栓塞术(7例);3)急诊手术(6例)。在第1组的88例患者中,71例(80.7%)出血停止,4例复发。在接受急诊支气管动脉栓塞术的7例患者中,6例(86%)出血停止,1例复发。在接受急诊手术的6例患者中,出血均停止,1例复发。复发性咯血通常在首次发作后7天内出现,通过支气管动脉栓塞术可得到良好控制。死亡率为17.8%。出院患者中,36.1%有复发性咯血。大多数复发出血发生在出院后一个月内。我们得出结论,大咯血最常见的原因是良性疾病而非恶性疾病。应大力应用保守治疗的重症监护。支气管动脉栓塞术是控制出血的一种极好的非手术替代方法,应在进行特定手术干预之前进行。